Axsome Therapeutics (AXSM) Shareholder's Equity Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.60% |
| Dec 31, 2025 | 54.86% |
| Sep 30, 2025 | -20.64% |
| Jun 30, 2025 | -28.95% |
| Mar 31, 2025 | -63.06% |
| Dec 31, 2024 | -70.15% |
| Sep 30, 2024 | -65.53% |
| Jun 30, 2024 | -63.11% |
| Mar 31, 2024 | 28.82% |
| Dec 31, 2023 | 74.32% |
| Sep 30, 2023 | 71.27% |
| Jun 30, 2023 | 1,734.36% |
| Mar 31, 2023 | 660.73% |
| Dec 31, 2022 | 600.89% |
| Sep 30, 2022 | 268.37% |
| Jun 30, 2022 | -78.72% |
| Mar 31, 2022 | -84.74% |
| Dec 31, 2021 | -86.26% |
| Sep 30, 2021 | -68.42% |
| Jun 30, 2021 | -53.69% |
| Mar 31, 2021 | -38.34% |
| Dec 31, 2020 | -36.33% |
| Sep 30, 2020 | 1,882.56% |
| Jun 30, 2020 | 535.19% |
| Mar 31, 2020 | 798.81% |
| Dec 31, 2019 | 18,955.16% |
| Sep 30, 2019 | 818.55% |
| Jun 30, 2019 | 246.46% |
| Mar 31, 2019 | 38.04% |
| Dec 31, 2018 | -94.39% |
| Sep 30, 2018 | -95.59% |
| Jun 30, 2018 | -69.20% |
| Mar 31, 2018 | -57.02% |
| Dec 31, 2017 | -22.50% |
| Sep 30, 2017 | -40.25% |
| Jun 30, 2017 | -34.81% |
| Mar 31, 2017 | -28.99% |
| Dec 31, 2016 | -53.55% |